- Oxford Biodynamics
- 20 October 2023 17:30:45
Source: Sharecast
Vulpes Testudo, which is controlled by non-executive director Stephen Diggle, sold the shares on Wednesday at an average price of 38.30p each, for a total value of £297,590.99.
Following the transaction, Diggle holds an interest in a total of 27.55m OBD shares, representing approximately 13.62% of the company's current issued share capital.
Earlier in October, Oxford BioDynamics successfully secured a proprietary laboratory analysis (PLA) code from the American Medical Association's Current Procedural Terminology Editorial Board. OBD said the unique code pertained to its EpiSwitch prostate screening test, which boasts a 94% accuracy.
As of 1530 BST, Oxford Biodynamics shares were up 2.25% at 34.80p.
Reporting by Iain Gilbert at Sharecast.com
Top Director Buys
Everyman Media Group (EMAN)
Director name: Rosehill,Michael
Amount purchased: 2,500,000 @ 55.00p
Value: �1,375,000.03
Oxford Cannabinoid Technologies Holdings (OCTP)
Director name: Mahapatra,Indraneil (Neil)
Amount purchased: 20,457,484 @ 0.81p
Value: �165,705.62
888 Holdings (di) (888)
Director name: Mendelsohn,Jonathan (Jon)
Amount purchased: 50,000 @ 79.50p
Value: �39,750.00
Top Director Sells
Ferguson (FERG)
Director name: Murphy,Kevin
Amount sold: 18,619 @ $164.54
Value: $2,526,213.08
Oxford Cannabinoid Technologies Holdings (OCTP)
Director name: Mahapatra,Indraneil (Neil)
Amount sold: 54,864,288 @ 0.81p
Value: �444,400.74
Oxford Biodynamics (OBD)
Director name: Diggle,Stephen Charles
Amount sold: 777,000 @ 38.30p
Value: �297,590.99